Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab for reducing complications in hospitalized COVID-19 patients
RBR-25rtydqPhase 3Completed
- Sponsor
- Lady Reading Hospital
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tocilizumab in coronavirus pneumonia, sponsored by Lady Reading Hospital. Started Apr 2020; status: completed.
02
Drugs
tocilizumab
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on RBR-25rtydq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-25rtydq.